Firms
Theme

BRO

Brown & Brown, Inc. · NYSE

News

9 latest

Zacks Investment Research

Is a Beat in the Cards for Brown & Brown This Earnings Season?

Brown & Brown (BRO) is projected to report Q3 2026 revenues of $1.76 billion (up 9.8%) and EPS of $1.08 (up 2.9%) on October 26. The company has a positive Earnings ESP of +1.62% and Zacks Rank #3, signaling potential for an earnings beat. Growth drivers include acquisitions, new business, and higher commissions, though rising expenses may provide headwinds.

GlobeNewswire Inc.

Brown & Brown, Inc. announces 9% increase in quarterly cash dividend rate

Brown & Brown, Inc. (NYSE: BRO) announced a regular quarterly cash dividend of $0.18 per share, representing a 9% increase from the previous $0.165 per share. This marks the company's 33rd consecutive annual dividend increase, payable on November 11, 2026. The insurance brokerage firm also announced it was named one of the 2026 Healthiest 100 Workplaces in America, ranking No. 25 nationally.

Zacks Investment Research

Curious about Brown & Brown (BRO) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Wall Street analysts forecast Brown & Brown will report Q3 earnings of $1.08 per share, representing a 2.9% year-over-year increase, with revenues expected at $1.76 billion, up 9.8% from the prior year. The consensus EPS estimate has been slightly revised downward by 0.1% in the past 30 days.

Zacks Investment Research

Aon (AON) Earnings Expected to Grow: Should You Buy?

Aon is expected to report Q3 2026 earnings of $3.34 per share with 2% revenue growth, but faces headwinds with a negative Earnings ESP of -0.80% and Zacks Rank #4, making an earnings beat unlikely. In contrast, peer Brown & Brown shows stronger prospects with a positive Earnings ESP of +1.62% and Zacks Rank #3, suggesting it is more likely to beat consensus estimates.

Zacks Investment Research

Top Research Reports for UnitedHealth, ServiceNow & 3M

Zacks Research Daily presents hand-picked analysis of 12 major stocks. UnitedHealth Group receives a Neutral rating despite strong Q3 earnings, citing regulatory scrutiny and premium valuation.

Zacks Investment Research

Brown & Brown (BRO) Earnings Expected to Grow: Should You Buy?

Brown & Brown (BRO) is expected to report Q3 2026 earnings on October 26 with consensus EPS of $1.08 (+2.9% YoY) and revenues of $1.76 billion (+9.9% YoY). The company has a positive Earnings ESP of +1.62% with a Zacks Rank #3 (Hold), suggesting a likely earnings beat. Historically, BRO has beaten consensus estimates in 3 of the last 4 quarters.

Zacks Investment Research

Can Willis Towers' Growth Momentum Continue Amid Soft Pricing?

Willis Towers Watson (WTW) achieved 5% organic revenue growth in Q2 2026, driven by its Risk & Broking segment (7% growth) and specialization strategy. The company maintains mid-single-digit growth guidance for 2026, though sustaining this pace depends on continued new business wins and offsetting softer insurance pricing. Peers Brown & Brown faced headwinds with declining organic growth, while Arthur J. Gallagher demonstrated stronger positioning with 6% organic growth expectations.

Mentions BRO

Zacks Investment Research

WTW Stock Trading at a Discount to Industry at 13.47X: Time to Hold?

Willis Towers Watson (WTW) reported solid Q2 organic growth across all segments, with R&B at 7%, HWC at 4%, and Insurance Consulting and Technology at 6%. The company's Propel AI initiative targets $400 million in annualized savings by 2028, supporting its 30% operating margin goal.

Zacks Investment Research

Can AI Products and Automation Drive WTW's Growth and Higher Margins?

Willis Towers Watson (WTW) is expanding AI-driven insurance technology capabilities through platforms like RiskIQ Nexus and Radar AI Assistant to improve risk management and underwriting. The company's Propel AI program targets $400 million in annualized savings by 2028, with $350 million retained after reinvestment.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $BRO · 0 threads

Sign in to post on $BRO

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev